Regeneron Pharmaceuticals (NASDAQ:REGN) reported its Q4 earnings results on Friday, February 4, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Check out this: Insiders Buying Charter Communications And 3 More Stocks
Earnings
Regeneron Pharmaceuticals beat estimated earnings by 30.98%, reporting an EPS of $23.72 versus an estimate of $18.11, which surprised analysts.
Revenue was up $2.53 billion from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $5.88, which was followed by a 5.57% drop in the share price the next day.
Here's a look at Regeneron Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 9.49 | 17.69 | 9.03 | 8.39 |
| EPS Actual | 15.37 | 25.80 | 9.89 | 9.53 |
| Revenue Estimate | 2.79B | 3.89B | 2.56B | 2.42B |
| Revenue Actual | 3.45B | 5.14B | 2.53B | 2.42B |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
